French pharma giant Sanofi SNY recently announced that it has agreed to acquire Massachusetts-based biotech Vigil ...

Eli Lilly (NYSE:LLY) has received regulatory approval to market its Alzheimer’s therapy Kisunla (donanemab) in Australia, ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...

Google became the gateway to the internet by perfecting its search engine. For two decades, it surfaced 10 blue links that ...

Sen. Susan Collins questioned Secretary of State Marco Rubio about the Trump administration's cutbacks to global health ...

A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...

The Food and Drug Administration has cleared the blood test to help diagnose Alzheimer's disease, potentially making it ...

Know the steps to take to protect yourself on social media. Watch the video. Help Register Login Login Hi, %{firstName}% Hi, ...

Eisai has put direct-to-consumer (DTC) advertising at the heart of its ongoing efforts to expand demand for Leqembi. | Eisai ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...